Both in vitro [214] and in vivo [215] data shows that curcumin-mediated inhibition of NF-κB activation enhances the sensitivity of prostate cancer cells to TRAIL-induced apoptosis. The gene discussed is NFKB1; the disease is prostate carcinoma.